Filing Details

Accession Number:
0000890465-13-000017
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-17 17:14:53
Reporting Period:
2013-09-16
Filing Date:
2013-09-17
Accepted Time:
2013-09-17 17:14:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
890465 Nps Pharmaceuticals Inc NPSP Biological Products, (No Disgnostic Substances) (2836) 870439579
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1299691 J Joseph Rogus 550 Hills Drive
Bedminster NJ 07921
Vp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-16 25,312 $8.25 44,684 No 4 M Direct
Common Stock Disposition 2013-09-16 21,012 $28.01 23,672 No 4 S Direct
Common Stock Disposition 2013-09-16 4,300 $28.63 19,372 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2013-09-16 25,312 $0.00 25,312 $8.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,688 2021-02-17 No 4 M Direct
Footnotes
  1. The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective August 14, 2013.
  2. The price shown above represents the weighted average price of the shares sold. The range of sales prices was $27.60 and $28.55. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
  3. The price shown above represents the weighted average price of the shares sold. The range of sales prices was $28.60 and $28.71. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
  4. Stock options granted under the 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. As of the date of this filing, 28,124 of the 45,000 stock options granted on February 17, 2011 have vested.